📣 VC round data is live. Check it out!

Ems-Chemie Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ems-Chemie and similar public comparables like DSM-Firmenich, Borouge, Albemarle, LyondellBasell and more.

Ems-Chemie Overview

About Ems-Chemie

Ems-Chemie Holding AG is a holding company that, through its subsidiaries, manufactures and sells a variety of chemical-based products. The firm organizes itself into two segments based on product type: High-Performance Polymers and Specialty Chemicals. The High-Performance Polymers segment, which generates the majority of revenue, sells plastic products to the automotive, electrical, and electronics industries. The Specialty Chemicals segment sells fibres, bonding agents for tires, and fusible bonding yarns for textiles and powder coating products. Geographically, the majority of its revenue comes from Europe and the rest from Asia, the Americas, and other regions.


Founded

1962

HQ

Switzerland

Employees

2.8K

Sectors

Financials (LTM)

Revenue: $2B
EBITDA: $804M

EV

$20B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ems-Chemie Financials

Ems-Chemie reported last 12-month revenue of $2B and EBITDA of $804M.

In the same LTM period, Ems-Chemie generated $1B in gross profit, $804M in EBITDA, and $610M in net income.

Revenue (LTM)


Ems-Chemie P&L

In the most recent fiscal year, Ems-Chemie reported revenue of $3B and EBITDA of $801M.

Ems-Chemie is profitable as of last fiscal year, with gross margin of 49%, EBITDA margin of 32%, and net margin of 24%.

See analyst estimates for Ems-Chemie
LTMLast FY202320242025202620272028
Revenue$2B$3B$3B$3B$2B
Gross Profit$1B$1B$1B$1B$1B
Gross Margin41%49%41%47%50%
EBITDA$804M$801M$694M$771M$793M
EBITDA Margin32%32%25%29%32%
EBIT Margin29%29%23%26%29%
Net Profit$610M$602M$585M$589M$597M
Net Margin24%24%21%22%24%

Financial data powered by Morningstar, Inc.

Ems-Chemie Stock Performance

Ems-Chemie has current market cap of $21B, and enterprise value of $20B.

Market Cap Evolution


Ems-Chemie's stock price is $892.74.

Ems-Chemie share price decreased by 2.3% in the last 30 days, and increased by 17.0% in the last year.

Ems-Chemie has an EPS (earnings per share) of $25.76.

See more trading valuation data for Ems-Chemie
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$20B$21B-2.3%-2.3%12.0%17.0%$25.76

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ems-Chemie Valuation Multiples

Ems-Chemie trades at 8.1x EV/Revenue multiple, and 25.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Ems-Chemie

EV / Revenue (LTM)


Ems-Chemie Financial Valuation Multiples

As of June 2, 2026, Ems-Chemie has market cap of $21B and EV of $20B.

Ems-Chemie has a P/E ratio of 34.2x.

LTMLast FY202320242025202620272028
EV/Revenue8.1x8.0x7.2x7.6x8.1x
EV/EBITDA25.1x25.2x29.0x26.1x25.4x
EV/EBIT27.5x27.6x31.9x29.2x27.7x
EV/Gross Profit19.6x16.3x17.7x16.2x16.3x
P/E34.2x34.7x35.7x35.4x35.0x
EV/FCF31.8x31.1x29.9x35.2x31.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ems-Chemie Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ems-Chemie Margins & Growth Rates

Ems-Chemie decreased revenue by 2% but EBITDA grew by 1% in the last fiscal year.

In the most recent fiscal year, Ems-Chemie reported gross margin of 49%, EBITDA margin of 32%, and net margin of 24%.

See estimated margins and future growth rates for Ems-Chemie

Ems-Chemie Margins

Last FY202420252026202720282029
Gross Margin49%47%50%42%
EBITDA Margin32%29%32%33%
EBIT Margin29%26%29%30%
Net Margin24%22%24%25%
FCF Margin26%22%26%25%

Ems-Chemie Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(2%)(5%)(6%)(1%)
Gross Profit Growth(17%)9%(0%)(17%)
EBITDA Growth1%11%3%2%
EBIT Growth1%9%5%1%
Net Profit Growth3%1%1%4%
FCF Growth(6%)(15%)13%(5%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ems-Chemie Operational KPIs

Ems-Chemie's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.2M for the same period.

Ems-Chemie's Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ems-Chemie's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Ems-Chemie
LTMLast FY202320242025202620272028
Rule of 4033%32%---
Bessemer Rule of X33%31%---
Revenue per Employee-$0.9M---
Opex per Employee-$0.2M---
G&A Expenses to Revenue-2%1%2%2%
Opex to Revenue-20%18%21%21%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ems-Chemie Competitors

Ems-Chemie competitors include DSM-Firmenich, Borouge, Albemarle, LyondellBasell, Industries Qatar, DuPont, International Flavors & Fragrances, Hengli Petrochemical, OMV and Qinghai Salt Lake Industry.

Most Ems-Chemie public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
DSM-Firmenich1.7x1.9x5.5x10.2x
Borouge4.0x3.9x10.6x10.5x
Albemarle4.5x4.2x21.1x12.9x
LyondellBasell1.1x1.0x13.1x8.7x
Industries Qatar4.0x4.3x10.4x13.1x
DuPont3.2x3.1x13.4x12.9x
International Flavors & Fragrances2.3x2.3x11.9x11.9x
Hengli Petrochemical1.2x1.1x9.5x8.8x

This data is available for Pro users. Sign up to see all Ems-Chemie competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ems-Chemie

See public comps similar to Ems-Chemie

Lists including Ems-Chemie

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial